Om du vill rapportera en biverkning gällande en av Lillys produkter, kontakta oss via e-post på DK_PHv@lilly.com eller på telefon +45 4526 6040. Har du ytterligare medicinska frågor gällande en av Lillys produkter, kontakta oss via länken ovan.
Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska
PCTFE/PE/PVC blisters sealed with an aluminium foil in a calendar blister card, in packs of 14, 28, 42, 56, 70 or 168 film-coated tablets.1
Aluminium/aluminium perforated unit dose blisters of 28 x 1 film-coated tablets.1
Not all pack sizes may be marketed.1
The abemaciclib dosage form is available in 50 mg, 100 mg, and 150 mg tablets, as shown inTable 1. Abemaciclib qualitative and quantitative composition
Table 1. Abemaciclib qualitative and quantitative composition1
Administration
Abemaciclib is for oral use.1
Patients should take the doses at approximately the same times every day.
The tablet should be swallowed whole (patients should not chew, crush, or split tablets before swallowing).1
If a patient vomits or misses a dose of abemaciclib, the patient should be instructed to take the next dose at its scheduled time; an additional dose should not be taken.1
Storage
This medicinal product does not require any special storage conditions.1
Disposal
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.1
1. Verzenios [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Glossary
MSDS = Material Safety Data Sheet
PCTFE = Polychlorotrifluoroethylene
PE = Polyethylene
PVC = Polyvinyl Chloride
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Datum fӧr senaste ӧversyn 2019 M01 03